- 专利标题： Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
-
申请号： US16837905申请日： 2020-04-01
-
公开(公告)号： US20200246433A1公开(公告)日： 2020-08-06
- 发明人: Sherry Bullens , Stuart Bunting , Tianwei Chou , Augustus O. Okhamafe , Christopher P. Price , Daniel J. Wendt , Clarence Yap
- 申请人： BioMarin Pharmaceutical Inc.
- 主分类号： A61K38/22
- IPC分类号： A61K38/22 ; A61K9/19 ; A61K47/12 ; A61K47/26 ; A61K47/18 ; A61K47/10 ; A61K9/00 ; A61K38/17
摘要：
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
公开/授权文献
信息查询
IPC分类:
